Gentamycin/poly(lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively. II. The case of Gentamycin sulfate (cas 1405-41-0) in high molecular weight poly(dl-lactic acid) and poly(l-lactic acid)
-
Add time:09/30/2019 Source:sciencedirect.com
In a second attempt to design a simple gentamycin delivery system usable for local antibiotic therapy administered per-operatively, bioresorbable particles were made by grinding and sieving the solid masses resulting from the mixing of various amounts of Gentamycin sulfate (cas 1405-41-0) (GS) with two high molecular weight poly(lactic acids), namely amorphous poly (dl-lactic acid), PLA50P, and semicrystalline poly(l-lactic acid), PLA100P. Under these conditions, GS crystals formed a solid dispersion within the polymer mass as deduced from SEM and X-ray diffraction. The polymer/drug particles were allowed to age in pH = 7.4, 0.13 M sodium phosphate buffer at 37°C. For PLA50P systems, the release profiles of gentamycin were biphasic with a burst effect followed by a phase of sustained release which lasted for more than two months. In contrast, the total loads were released within less than 6 h, in the case of PLA100P systems. The difference between release characteristics observed for the amorphous and the semicrystalline PLA/GS systems was due to differences of morphologies and not to differences of degradation rates. The dependence of release profiles on particle size and on drug load was also investigated. Only 0.5–1 mm, 10% w/w GS-loaded PLA50P particles gave release rates compatible with the requirements for local antibiotic therapy.
We also recommend Trading Suppliers and Manufacturers of Gentamycin sulfate (cas 1405-41-0). Pls Click Website Link as below: cas 1405-41-0 suppliers
Prev:Document headingModulatory effects of dietary inclusion of garlic (Allium sativum) on gentamycin–induced hepatotoxicity and oxidative stress in rats
Next:ResearchEffects of feeding generic ractopamine (Actogain) with or without the combination of monensin and Tylosin phosphate (cas 1405-53-4) on growth performance, carcass characteristics, and tenderness of finishing steers) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Document headingModulatory effects of dietary inclusion of garlic (Allium sativum) on gentamycin–induced hepatotoxicity and oxidative stress in rats09/29/2019
- Development of an enzyme-linked immunosorbent assay for the detection of gentamycin residues in animal-derived foods09/28/2019
- Gentamycin/poly (lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively. III. The case of Gentamycin sulfate (cas 1405-41-0) in films prepared from high and low molecular weight poly (DL-lactic acids)10/01/2019
- Renoprotective effects of stevia (Stevia rebaudiana Bertoni), amlodipine, valsartan, and losartan in gentamycin-induced nephrotoxicity in the rat model: Biochemical, hematological and histological approaches09/27/2019
- Gentamycin/poly(lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively. I. The case of gentamycin base and Gentamycin sulfate (cas 1405-41-0) in poly(dl-lactic acid) oligomers09/26/2019
- Development of a novel bead-based 96-well filtration plate competitive immunoassay for the detection of Gentamycin09/25/2019
- Augmented debridement for implant related chronic osteomyelitis with an absorbable, gentamycin loaded calcium sulfate/hydroxyapatite biocomposite09/24/2019